The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
The Stock Idea & Analysis Community
SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.
Top_member_photos
Get free stock picks and email alerts daily
 
Are you a stock guru?

 amritadas     Graphic_subscribe   

    Start Tracking amritadas  -  Add to Friends  -  Send Message   
    Community Rank: Sr. Analyst (334 pts)  |  Member since 07/27/2009
Picks Performance:
N/A

No percentile ranking
has been calculated.


All-time Return
+0.00%
(in 3 months)
Risk (SD)
N/A
N/A
Sharpe Ratio
N/A
Followers
0
Winning Picks
0 of 0
Total Views
11062


amritadas hasn't made any stock picks yet.


Discussions

A FREE report on upcoming FDA decision for small cap comp... 08/03/09
FDA decision date coming up this month for small cap company's Pain drug. If the FDA approves the drug, the peak sales could reach over 200% of the company's current market cap. Given the mechanism of action, the road to approval perhaps may not be as smooth for this company. To read about our opinion on whether the drug will be approved or not, as well as other important info about the drug,...

A FREE report on upcoming FDA decision for small cap comp... 08/03/09
FDA decision date coming up this month for small cap company's Pain drug. If the FDA approves the drug, the peak sales could reach over 200% of the company's current market cap. Given the mechanism of action, the road to approval perhaps may not be as smooth for this company. To read about our opinion on whether the drug will be approved or not, as well as other important info about the drug,...

A FREE report on upcoming FDA decision for small cap comp... 08/03/09
FDA decision date coming up this month for small cap company's Pain drug. If the FDA approves the drug, the peak sales could reach over 200% of the company's current market cap. Given the mechanism of action, the road to approval perhaps may not be as smooth for this company. To read about our opinion on whether the drug will be approved or not, as well as other important info about the drug,...

A FREE report on upcoming FDA decision for small cap comp... 08/03/09
FDA decision date coming up this month for small cap company's Pain drug. If the FDA approves the drug, the peak sales could reach over 200% of the company's current market cap. Given the mechanism of action, the road to approval perhaps may not be as smooth for this company. To read about our opinion on whether the drug will be approved or not, as well as other important info about the drug,...

A FREE report on upcoming FDA decision for small cap comp... 08/03/09
FDA decision date coming up this month for small cap company's Pain drug. If the FDA approves the drug, the peak sales could reach over 200% of the company's current market cap. Given the mechanism of action, the road to approval perhaps may not be as smooth for this company. To read about our opinion on whether the drug will be approved or not, as well as other important info about the drug,...

A FREE report on upcoming FDA decision for small cap comp... 08/03/09
FDA decision date coming up this month for small cap company's Pain drug. If the FDA approves the drug, the peak sales could reach over 200% of the company's current market cap. Given the mechanism of action, the road to approval perhaps may not be as smooth for this company. To read about our opinion on whether the drug will be approved or not, as well as other important info about the drug,...

A FREE report on upcoming FDA decision for small cap comp... 08/03/09
FDA decision date coming up this month for small cap company's Pain drug. If the FDA approves the drug, the peak sales could reach over 200% of the company's current market cap. Given the mechanism of action, the road to approval perhaps may not be as smooth for this company. To read about our opinion on whether the drug will be approved or not, as well as other important info about the drug,...

A FREE report on upcoming FDA decision for small cap comp... 08/03/09
FDA decision date coming up this month for small cap company's Pain drug. If the FDA approves the drug, the peak sales could reach over 200% of the company's current market cap. Given the mechanism of action, the road to approval perhaps may not be as smooth for this company. To read about our opinion on whether the drug will be approved or not, as well as other important info about the drug,...

A FREE report on upcoming FDA decision for small cap comp... 08/03/09
FDA decision date coming up this month for small cap company's Pain drug. If the FDA approves the drug, the peak sales could reach over 200% of the company's current market cap. Given the mechanism of action, the road to approval perhaps may not be as smooth for this company. To read about our opinion on whether the drug will be approved or not, as well as other important info about the drug,...

A FREE report on upcoming FDA decision for small cap comp... 08/03/09
FDA decision date coming up this month for small cap company's Pain drug. If the FDA approves the drug, the peak sales could reach over 200% of the company's current market cap. Given the mechanism of action, the road to approval perhaps may not be as smooth for this company. To read about our opinion on whether the drug will be approved or not, as well as other important info about the drug,...




People Following amritadas ...

Nobody is following amritadas.






ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.25% 378
2 18.14 +70.10% 208
3 17.66 +25.70% 55
4 13.47 +14.32% 61
5 12.13 +75.30% 38


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Similarity to Me   ?

Compare Your Portfolio With amritadas:
Enter stocks you like & track your portfolio:

Symbols, separated by space (e.g. AAPL GOOG MSFT)



More about amritadas

Avg exp holding time:
No closed positions





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch